$60,000 of ABBOTT LABORATORIES lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to federal tax policy. Issues related to medical device reimbursement, cybersecurity, and supply chains. Issues related to diagnostic testing. Issues related to the supply of infant formula and nutrition."
You can find more data on corporate lobbying on Quiver Quantitative.
ABT Congressional Stock Trading
Members of Congress have traded $ABT stock 11 times in the past 6 months. Of those trades, 3 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/12 and 1 sale worth up to $15,000 on 07/30.
- REPRESENTATIVE MIKE KELLY sold up to $15,000 on 07/17.
- REPRESENTATIVE RICK W. ALLEN has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 07/14, 04/16.
- REPRESENTATIVE RICK LARSEN sold up to $15,000 on 07/08.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/16 and 1 sale worth up to $15,000 on 05/15.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 05/27.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
ABT Insider Trading Activity
ABT insiders have traded $ABT stock on the open market 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:
- ROBERT B FORD (CHAIRMAN AND CEO) has made 0 purchases and 2 sales selling 398,832 shares for an estimated $46,204,798.
- DANIEL J STARKS purchased 10,000 shares for an estimated $926,537
- LOUIS H. MORRONE (EXECUTIVE VICE PRESIDENT) sold 5,850 shares for an estimated $642,505
- PHILIP P BOUDREAU (EVP AND CFO) purchased 2,200 shares for an estimated $201,300
- JOHN G STRATTON purchased 2,000 shares for an estimated $173,640
- JOHN A. JR. MCCOY (VICE PRESIDENT AND CONTROLLER) sold 27 shares for an estimated $2,957
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ABT Hedge Fund Activity
We have seen 1,203 institutional investors add shares of ABT stock to their portfolio, and 1,638 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 59,674,507 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,414,864,765
- WELLINGTON MANAGEMENT GROUP LLP removed 18,765,809 shares (-69.3%) from their portfolio in Q2 2026, for an estimated $1,702,809,508
- JPMORGAN CHASE & CO added 15,095,898 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,369,801,784
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 14,174,452 shares (+31.2%) to their portfolio in Q2 2026, for an estimated $1,286,189,774
- CAPITAL RESEARCH GLOBAL INVESTORS removed 12,866,372 shares (-25.8%) from their portfolio in Q2 2026, for an estimated $1,167,494,595
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 12,502,246 shares (-97.9%) from their portfolio in Q2 2026, for an estimated $1,134,453,802
- BLACKROCK, INC. added 6,876,018 shares (+4.7%) to their portfolio in Q2 2026, for an estimated $623,929,873
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ABT Price Targets
Multiple analysts have issued price targets for $ABT recently. We have seen 10 analysts offer price targets for $ABT in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $112.0 on 07/06/2026
- David Rescott from Baird set a target price of $121.0 on 07/01/2026
- Adam Maeder from Piper Sandler set a target price of $115.0 on 06/22/2026
- Marie Thibault from BTIG set a target price of $131.0 on 04/27/2026
- Matt Miksic from Barclays set a target price of $143.0 on 04/20/2026
- Travis Steed from B of A Securities set a target price of $120.0 on 04/17/2026
- Rick Wise from Stifel set a target price of $120.0 on 04/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
